Igyxos
About:
Igyxos is a biotech startup developing a new treatment for female and male infertility that works by shifting hormal imbalances.
Website: http://www.igyxos.com/
Top Investors: Bpifrance, GO CAPITAL, Sofimac Innovation
Description:
Igyxos’ mission is to develop innovative new pharmaceuticals and medical technologies in the field of human fertility. Igyxos is involved in all phases of development, from the discovery of promising targets to the identification of potential lead compounds such as small molecules and antibodies, and the acquisition of intellectual property rights to drugs and technologies that can then be brought to the development phase. Igyxos also support the transfer of potential drug candidates to pre-clinical and clinical phases of drug development.
7.5M EUR
$1M to $10M
Nouzilly, Centre, France
2017-01-01
contact(AT)igyxos.com
Marie-Christine Maurel
1-10
2019-03-21
Private
© 2025 bioDAO.ai